In addition to this IDO-mediated regulation of anti-melanoma immunity, regulatory pDC have also been shown to drive TH2 and Treg differentiation of CD4+ T cells through cell–cell interactions via OX40L and ICOSL, respectively (131). This evidence concerns the gene IDO1 and melanoma.